M. Mutambanengwe

Microwave ablation determines similar survival outcomes as compared to radiofrequency ablation for the treatment of hepatocellular carcinoma

A. Khan, A. Facciorusso, Marcin Mostowy, 2020, Expert review of gastroenterology & hepatology.

Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial

B. Chi, D. Moodley, G. Theron, 2022, BMC Infectious Diseases.

Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa

Michael I. Jordan, Donald A. Jackson, J. G. Ndirangu, 2016, Journal of the International AIDS Society.

Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial

S. Delany-Moretlwe, J. Hughes, B. G. Mirembe, 2022, The Lancet.

Pharmacokinetics and Drug‐Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of Genotyping

G. Montepiedra, T. Sterling, D. Haas, 2020, Clinical pharmacology and therapeutics.

Slow Acceptance of Universal Antiretroviral Therapy (ART) Among Mothers Enrolled in IMPAACT PROMISE Studies Across the Globe

L. Aurpibul, J. Currier, M. Fowler, 2019, AIDS and Behavior.

Prevalence of neurotoxicity symptoms among postpartum women on isoniazid preventive therapy and efavirenz-based treatment for HIV: an exploratory objective of the IMPAACT P1078 randomized trial

G. Montepiedra, L. Mokgatlhe, W. El-Sadr, 2023, BMC Pregnancy and Childbirth.

Timing of maternal isoniazid preventive therapy on tuberculosis infection among infants exposed to HIV in low-income and middle-income settings: a secondary analysis of the TB APPRISE trial.

G. Montepiedra, T. Sterling, G. Theron, 2023, The Lancet. Child & adolescent health.